CClinicalTrials.gg
RecruitingNCT06920342GRACEFULUpdated Apr 9, 2025

Attitudes to Gynae Oncology Care Location - GRACEFUL

An observational study in Gynecologic Cancers, sponsored by Somerset NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-09.

Sponsored by Somerset NHS Foundation Trust · Observational

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 6 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
600
Ages
18 Years and older
Sex
Female
01

Study summary

Gynaecological oncology (cancer) place of care is often based on evolution of services, along historical professional boundaries, rather than user needs or preferences. The investigators aim to gather views of patients in the United Kingdom (UK) on their preferred place of care for investigation, treatment and follow-up of gynaecological cancer. An initial scoping review found no previous work in this area. Pilot work, performed to inform local re-organisation of services, found that 53% of participants were somewhat or very unhappy to have care co-located with O\&G services. Specifically, two key themes were identified through content analysis of free-text comments: "environment and getting this right is vital"; and "our cancer should be the priority".

However, via a BGCS survey, the investigator found that healthcare professionals (HCPs) underestimated strong patient preferences. Of those who see patients within O\&G services, only 50% said patients were seen at separate times/locations from obstetric patients. The investigators want to expand on these pilot data to better understand how to design services that better meet our patients' needs. The investigators will conduct a survey to ascertain service users' attitudes to location of services, collecting quantitative data \& qualitative data, including opportunities for feedback in free text. The investigator will conduct analysis using standard statistical methods \& content analysis of free-text responses. Submissions will be anonymous \& no identifiable data will be collected routinely, unless volunteered by the respondent. The investigator will ask a subset of \~30 participants to undertake a telephone/virtual-based semi-structured interview to further explore understanding on attitudes to location of care more generally. A topic guide will be developed, informed by the Theoretical Framework of Acceptability. Interviews will be audio-recorded with consent, transcribed verbatim \& anonymised. The anonymised transcripts will be analysed using a form of Thematic Analysis. These findings should help to shape future health care service sensitive to patient need.

02

Conditions studied

  • Gynecologic Cancers
03

In context

Lead sponsor

Somerset NHS Foundation Trust is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

UK

Inclusion criteria

  • Female Aged 18 or over Able to give informed consent Have been referred to secondary care with a suspected gynaecological cancer, or have previously been diagnosed with a gynaecological malignancy

Exclusion criteria

Exclusion Criteria:

  • Male Unable to give informed consent
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
600 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Graceful 1

    Patient-reported outcomes of acceptability of different clinic co-locations and the impact of different services.

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06920342
Lead sponsor
Somerset NHS Foundation Trust
Responsible party
Sponsor
First posted
Apr 9, 2025
Start date
Mar 24, 2025
Primary completion
Feb 2, 2029 (estimated)
Completion
Feb 2, 2029 (estimated)
Last update
Apr 9, 2025

Study contacts

Dr Jo Morrison
Contact
jo.morrison@somersetft.nhs.uk
+44 1823342562
Flo Cullen
Contact
Flo.Cullen@somersetft.nhs.uk
+44 01823 342582

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion